Overly conservative FDA label likely prevents use of metformin in many type 2 diabetics, experts say

Many patients with type 2 diabetes in the United States may be discouraged from taking metformin–a proven, oral diabetes medicine–because the U.S. Food and Drug Administration inappropriately labels the drug unsafe for some patients also suffering from kidney problems, researchers report.